Search Results 1291-1300 of 16820 for FODMAP

  1. Mayo Clinic

    An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20522540.

  2. A Study of the Incidence of Post Lumbar Puncture Headache in the Outpatient Setting - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. A Study of Adults 65 Years or Older to Establish Normal Lymphocyte Subsets and Immunoglobulin Levels - Mayo Clinic

    The purpose of this study is to evaluate baseline lymphocyte subsets and immunoglobulin levels in adults ≥ 65 years without clinical suspicion of ...

  4. A Registry and Biospecimen Collection to Advance the Diagnosis and Care of Patients with Glomerular Diseases - Mayo Clinic

    Aim 2 (Biomarkers). To identify and characterize clinical, histological, molecular, and genetic biomarkers that are linked to glomerular disease, disease ...

  5. Phase 2 Trial of Blinatumomab in Philadelphia Positive/BCR-ABL Positive Acute Lymphoblastic Leukemia - Mayo Clinic

    This is a single-arm Simon II stage design, multicenter study consisting of a screening period, an induction treatment period (2 cycles of blinatumomab), a ...

  6. Complex regional pain syndrome - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  7. Surgery - Doctors - Mayo Clinic

    Mayo Clinic Surgery offers deep expertise and a wide range of surgical care to tens of thousands of people each year.

  8. Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) - Mayo Clinic

    Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem ...

  9. A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) - Mayo Clinic

    About this study. Phase I Dose Escalation: Primary objective is to determine the MTD and the recommended dose for Phase I Extension.

  10. Mayo Clinic

    An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20453014.